05 HB 416/AP
House
Bill 416 (AS PASSED HOUSE AND SENATE)
By:
Representatives Ralston of the
7th,
Ehrhart of the
36th,
Coleman of the
144th,
and Parrish of the
156th
A
BILL TO BE ENTITLED
AN ACT
AN ACT
To
amend Title 51 of the Official Code of Georgia Annotated, relating to torts, so
as to change provisions relating to asbestos claims and silica claims; to
provide for applicability; to provide definitions; to provide that physical
impairment shall be an essential element of an asbestos claim or a silica claim;
to provide for a limitations period for filing a claim; to provide for dismissal
of pending claims under certain conditions; to provide for general rules
applicable to new filings; to provide for forum non conveniens; to provide for
venue; to provide for joinder and consolidation of claims; to provide for other
matters relative to the foregoing; to provide for severability; to provide an
effective date; to repeal conflicting laws; and for other purposes.
BE
IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:
SECTION
1.
Title
51 of the Official Code of Georgia Annotated, relating to torts, is amended by
inserting at the end thereof a new Chapter 14 to read as follows:
"CHAPTER
14
51-14-1.
This
chapter applies to any claim defined in this chapter as an asbestos claim or as
a silica claim.
51-14-2.
As
used in this chapter, the term:
(1)
'Asbestos' means chrysotile, amosite, crocidolite, tremolite asbestos,
anthophyllite asbestos, actinolite asbestos, and any of these minerals that have
been chemically treated or altered, including but not limited to all minerals
defined as asbestos in 29 CFR 1910, as amended from time to time.
(2)
'Asbestos claim' means any claim, wherever or whenever made, for damages,
losses, indemnification, contribution, loss of consortium, or other relief
arising out of, based on, or in any way related to the health effects of
exposure to asbestos, including, but not limited to:
(A)
Any claim for:
(i)
Personal injury or death;
(ii)
Mental or emotional injury;
(iii)
Risk of disease or other injury; or
(iv)
The costs of medical monitoring or surveillance, to the extent such claims are
recognized under state law; and
(B)
Any claim made by or on behalf of an exposed person or based on that exposed
persońs
exposure to asbestos, including a representative, spouse, parent, child, or
other relative of the exposed person.
For
purposes of this chapter, 'asbestos claim' shall not mean a claim brought under
a
workerś
compensation law administered by this state to provide benefits, funded by a
responsible employer or its insurance carrier, for occupational diseases or
injuries or for disability or death caused by occupational diseases or
injuries.
(3)
'Asbestosis' means bilateral diffuse interstitial fibrosis of the lungs caused
by inhalation of asbestos.
(4)
'Board certified internist' means a qualified physician licensed to practice
medicine who has treated or is treating the exposed person or has or had a
doctor-patient relationship with the exposed person and who is currently
certified by the American Board of Internal Medicine.
(5)
'Board certified pathologist' means a qualified physician licensed to practice
medicine who holds primary certification in anatomic pathology or combined
anatomic or clinical pathology from the American Board of Pathology and whose
professional practice is principally in the field of pathology and involves
regular evaluation of pathology materials obtained from surgical or post-mortem
specimens.
(6)
'Board certified pulmonologist' means a qualified physician licensed to practice
medicine who has treated or is treating the exposed person or has or had a
doctor-patient relationship with the exposed person and who is currently
certified by the American Board of Internal Medicine in the subspecialty of
pulmonary medicine.
(7)
'Certified B-reader' means a qualified physician who has successfully passed the
B-reader certification examination for X-ray interpretation sponsored by the
National Institute for Occupational Safety and Health and whose certification
was current at the time of any readings required by this chapter.
(8)
'Chest X-rays' means films taken in two views (PA and Lateral) and graded
quality 1 for reading in accordance with the radiological standards
established by the International Labor Office, as interpreted by a certified
B-reader.
(9)
'Claimant' means a party seeking recovery of damages for an asbestos claim or
silica claim, including the exposed person, any other plaintiff making a claim
as a result of the exposed
persońs
exposure to asbestos or silica, counterclaimant, cross-claimant, or third-party
plaintiff. If a claim is brought through or on behalf of an estate, the term
includes the
claimant́s
decedent; if a claim is brought through or on behalf of a minor or incompetent,
the term includes the
claimant́s
parent or guardian.
(10)
'Exposed person' means any person whose exposure to asbestos or silica is the
basis for an asbestos claim or a silica claim.
(11)
'FEV-1' means forced expiratory volume in the first second, which is the maximal
volume of air expelled in one second during performance of simple spirometric
tests.
(12)
'FVC' means forced vital capacity, which is the maximal volume of air expired
with maximum effort from a position of full inspiration.
(13)
'ILO system' means the radiological ratings of the International Labor Office
set forth in
Guidelines for the Use
of ILO International Classification of Radiographs of
Pneumoconioses, revised edition, as
amended from time to time by the International Labor Office.
(14)
'Lower limit of normal' means the fifth percentile of healthy populations based
on age, height, and gender, as referenced in the American Medical
Associatiońs
Guides to the
Evaluation of Permanent Impairment, fifth
edition, as amended from time to time by the American Medical
Association.
(15)
In the context of an asbestos claim, 'prima-facie evidence of physical
impairment' means:
(A)
That a board certified pathologist has made a diagnosis of pleural or peritoneal
mesothelioma, or a diagnosis of cancer demonstrated by a medical report showing
the diagnosis as a primary cancer, and has signed a report certifying to a
reasonable degree of medical certainty that exposure to asbestos was a
substantial contributing factor to the diagnosed cancer and that it was not more
probably the result of causes other than the asbestos exposure revealed by the
exposed
persońs
employment and medical histories; or
(B)
That a board certified internist, pulmonologist, or pathologist has signed a
detailed narrative medical report and diagnosis stating that the exposed person
suffers from a nonmalignant disease related to asbestos and that:
(i)
Verifies that the doctor signing the detailed narrative medical report and
diagnosis or a medical professional employed by and under the direct supervision
and control of that doctor has taken:
(I)
A detailed occupational and exposure history from the exposed person or, if that
person is deceased, from the person most knowledgeable about the exposures that
form the basis for the action. The history shall include all of the exposed
persońs
principal employments and his or her exposures to airborne contaminants that can
cause pulmonary impairment, including, but not limited to, asbestos, silica, and
other disease-causing dusts, and the nature, duration, and level of any such
exposure; and
(II)
A detailed medical and smoking history that includes a thorough review of the
exposed
persońs
past and present medical problems and their most probable cause;
(ii)
Sets out the details of the occupational, medical, and smoking histories and
verifies that at least 15 years have elapsed between the exposed
persońs
first exposure to asbestos and the time of diagnosis;
(iii)
Verifies that the exposed person has:
(I)
An ILO quality 1 chest X-ray taken in accordance with all applicable state and
federal regulatory standards, and that the X-ray has been read by a certified
B-reader according to the ILO system of classification as showing bilateral
small irregular opacities (s, t, or u) graded 1/1 or higher or bilateral diffuse
pleural thickening graded b2 or higher including blunting of the costophrenic
angle; provided, however, that in a death case where no pathology is available,
the necessary radiologic findings may be made with a quality 2 film if a quality
1 film is not available; or
(II)
Pathological asbestosis graded 1(B) or higher under the criteria published in
the Asbestos-Associated Diseases, Special Issue of the
Archives of
Pathological and Laboratory Medicine,
Volume 106, Number 11, Appendix 3, as amended from time to time;
(iv)
Verifies that the exposed person has pulmonary impairment related to asbestos as
demonstrated by pulmonary function testing, performed using equipment, methods
of calibration, and techniques that meet the criteria incorporated in the
American Medical
Associatiońs
Guides to the
Evaluation of Permanent Impairment, fifth
edition, and reported as set forth in 20 CFR 404, Subpt. P. App 1, Part (A)
Section 3.00 (E) and (F), as amended from time to time by the American Medical
Association, and the interpretative standards of the American Thoracic Society,
Lung Function Testing:
Selection of Reference Values and Interpretive
Strategies, 144 Am. Rev. Resp. Dis.
1202-1218 (1991), as amended from time to time by the American Thoracic Society,
that shows:
(I)
Forced vital capacity below the lower limit of normal and FEV1/FVC ratio, using
actual values, at or above the lower limit of normal; or
(II)
Total lung capacity, by plethysmography or timed gas dilution, below the lower
limit of normal; and
(v)
Verifies that the doctor signing the detailed narrative medical report and
diagnosis has concluded that exposure to asbestos was a substantial contributing
factor to the exposed
persońs
medical condition and physical impairment and that they were not more probably
the result of other causes revealed by the exposed
persońs
employment and medical histories.
Copies
of the B-reading, the pulmonary function tests, including printouts of the flow
volume loops and all other elements required to demonstrate compliance with the
equipment, quality, interpretation, and reporting standards set forth herein,
and the diagnosing
physiciańs
detailed narrative medical report and diagnosis shall be attached to any
complaint alleging nonmalignant disease related to exposure to asbestos. All
such reports, as well as all other evidence used to establish prima-facie
evidence of physical impairment, must meet objective criteria for generally
accepted medical standards related to exposure to asbestos and must not be
obtained through testing or examinations that violate any applicable law,
regulation, licensing requirement, or medical code of practice. Failure to
attach the required reports or demonstration by any party that the reports do
not satisfy the standards set forth herein shall result in the dismissal of the
action, without prejudice, upon motion of any party.
(16)
In the context of a silica claim, 'prima-facie evidence of physical impairment'
means:
(A)
A written diagnosis of silica related lung cancer demonstrated by:
(i)
A medical report showing the diagnosis as a diagnosis of a primary lung cancer;
and
(ii)
A signed report certified by a board certified internist, pulmonologist, or
pathologist stating to a reasonable degree of medical probability that exposure
to silica was the cause of the diagnosed lung cancer with underlying silicosis
demonstrated by bilateral nodular opacities (p, q, or r) occurring primarily in
the upper lung fields, graded 1/1 or higher and not more probably the result of
causes other than the silica exposure revealed by the exposed
persońs
employment and medical histories;
(B)
A written diagnosis of silica related progressive massive fibrosis or acute
silicoproteinosis; or silicosis complicated by documented tuberculosis,
demonstrated by a signed report certified by a board certified internist,
pulmonologist, or pathologist; or
(C)
That a board certified internist, pulmonologist, or pathologist has signed a
detailed narrative medical report and diagnosis stating that the exposed person
suffers from other stages of nonmalignant disease related to silicosis other
than those set forth in subparagraphs (A) and (B) of this paragraph, and
that:
(i)
Verifies that the doctor signing the detailed narrative medical report and
diagnosis or a medical professional employed by and under the direct supervision
and control of that doctor has taken:
(I)
A detailed occupational and exposure history from the exposed person or, if that
person is deceased, from the person most knowledgeable about the exposures that
form the basis for the action. The history shall include all of the exposed
persońs
principal employments and his or her exposures to airborne contaminants that can
cause pulmonary impairment, including, but not limited to, asbestos, silica, and
other disease-causing dusts, and the nature, duration, and level of any such
exposure; and
(II)
A detailed medical and smoking history that includes a thorough review of the
exposed
persońs
past and present medical problems and their most probable cause;
(ii)
Sets out the details of the occupational, medical, and smoking histories and
verifies a sufficient latency period for the applicable stage of
silicosis;
(iii)
Verifies that the exposed person has at least Class 2 or higher impairment due
to silicosis, as set forth in the American Medical
Associatiońs
Guides to the
Evaluation of Permanent Impairment, fifth
edition, as amended from time to time; and
(I)
An ILO quality 1 chest X-ray taken in accordance with all applicable state and
federal regulatory standards, and that the X-ray has been read by a certified
B-reader according to the ILO system of classification as showing bilateral
nodular opacities (p, q, or r) occurring primarily in the upper lung fields,
graded 1/1 or higher; provided, however, that in a death case where no
pathology is available, the necessary radiologic findings may be made with a
quality 2 film if a quality 1 film is not available; or
(II)
Pathological demonstration of classic silicotic nodules exceeding 1 centimeter
in diameter as set forth in
Archives of
Pathological & Laboratory Medicine,
July, 1988, as amended from time to time; and
(iv)
Verifies that the doctor signing the detailed narrative medical report and
diagnosis has concluded that the exposure to silica is a substantial
contributing factor to the exposed
persońs
medical condition and physical impairment and that they were not more probably
the result of other causes revealed by the exposed
persońs
employment and medical history.
Copies
of the B-reading, the pulmonary function tests, including printouts of the flow
volume loops and all other elements required to demonstrate compliance with the
equipment, quality, interpretation, and reporting standards set forth herein,
and the diagnosing
physiciańs
detailed narrative medical report and diagnosis shall be attached to any
complaint alleging nonmalignant disease related to exposure to silicosis. All
such reports, as well as all other evidence used to establish prima-facie
evidence of physical impairment, must meet objective criteria for generally
accepted medical standards related to exposure to silica and must not be
obtained through testing or examinations that violate any applicable law,
regulation, licensing requirement, or medical code of practice. Failure to
attach the required reports or demonstration by any party that the reports do
not satisfy the standards set forth herein shall result in the dismissal of the
action, without prejudice, upon motion of any party.
(17)
'Qualified physician' means a medical doctor, who:
(A)
Spends no more than 10 percent of his or her professional practice time in
providing consulting or expert services in connection with actual or potential
civil actions, and whose medical group, professional corporation, clinic, or
other affiliated group earns not more than 20 percent of its revenues from
providing such services;
(B)
Receives or received payment for the treatment of the exposed person from that
person or from that
persońs
health maintenance organization or other medical provider; and
(C)
Does not require as a condition of diagnosing, examining, testing, screening, or
treating the exposed person that legal services be retained by the exposed
person or any other person pursuing an asbestos or silica claim based on the
exposed
persońs
exposure to asbestos or silica.
(18)
'Silica' means a group of naturally occurring crystalline forms of silicon
dioxide, including, but not limited to, quartz and silica sand, whether in the
form of respirable free silica or any quartz-containing or crystalline
silica-containing dust, in the form of a quartz-containing by-product or
crystalline silica-containing by-product, or dust released from individual or
commercial use, release, or disturbance of silica sand, silicon dioxide, or
crystalline-silica containing media, consumables, or materials.
(19)
'Silica claim' means any claim, wherever or whenever made, for damages, losses,
indemnification, contribution, loss of consortium, or other relief arising out
of, based on, or in any way related to the health effects of exposure to silica,
including, but not limited to:
(A)
Any claim for:
(i)
Personal injury or death;
(ii)
Mental or emotional injury;
(iii)
Risk of disease or other injury; or
(iv)
The costs of medical monitoring or surveillance, to the extent such claims are
recognized under state law; and
(B)
Any claim made by or on behalf of any exposed person or based on that exposed
persońs
exposure to silica, including a representative, spouse, parent, child, or other
relative of the exposed person.
For
purposes of this chapter, 'silica claim' shall not mean a claim brought under a
workerś
compensation law administered by this state to provide benefits, funded by a
responsible employer or its insurance carrier, for occupational diseases or
injuries or for disability or death caused by occupational diseases or
injuries.
(20)
'Silicosis' means nodular interstitial fibrosis of the lung produced by
inhalation of silica.
(21)
'Total lung capacity' means the volume of gas contained in the lungs at the end
of a maximal inspiration.
51-14-3.
(a)
Prima-facie evidence of physical impairment of the exposed person as defined in
paragraph (15) or (16) of Code Section 51-14-2 shall be an essential element of
an asbestos claim or silica claim.
(b)
No person shall bring or maintain a civil action alleging an asbestos claim or
silica claim in the absence of prima-facie evidence of physical impairment
resulting from a medical condition for which exposure to asbestos or silica was
a substantial contributing factor.
51-14-4.
Notwithstanding
any other provision of law, with respect to any asbestos claim or silica claim
not barred as of the effective date of this chapter, the limitations period
shall not begin to run until the exposed person or any plaintiff making an
asbestos claim or silica claim based on the exposed
persońs
exposure to asbestos or silica discovers, or through the exercise of reasonable
diligence should have discovered, that the exposed person is or was physically
impaired as defined in paragraph (15) or (16) of Code Section
51-14-2.
51-14-5.
(a)
Any asbestos claim or silica claim pending in this state on the effective date
of this chapter shall be dismissed within 180 days of the effective date of this
chapter without prejudice unless:
(1)
All parties stipulate by no less than 60 days prior to the commencement of trial
that the plaintiff has established prima-facie evidence of physical impairment
with respect to an asbestos claim or silica claim; or
(2)
The trial court in which the complaint was initially filed issues an order that
the plaintiff has established prima-facie evidence of physical impairment with
respect to an asbestos claim or silica claim. Such an order shall be issued only
if the following conditions and procedures are met:
(A)
By no less than 60 days prior to the commencement of trial, the plaintiff files
with the trial court and serves on each defendant named in the complaint or on
counsel designated by each defendant the medical documentation necessary to
establish prima-facie evidence of physical impairment;
(B)
Within 30 days of service of
plaintiff́s
documentation establishing prima-facie evidence of physical impairment, any
defendant may file an opposition with the trial court challenging
plaintiff́s
prima-facie evidence of physical impairment. To the extent any such opposition
is based upon the medical opinion of a licensed physician, that physician shall
be a qualified physician, as that term is defined in subparagraph (A) of
paragraph (17) of Code Section 51-14-2, and shall be either a board certified
internist, a board certified pathologist, a board certified pulmonologist, or a
certified B-reader.
Defendant́s
opposition shall be filed with the trial court and served on
plaintiff́s
counsel and each defendant;
(C)
If a defendant does not file an opposition within the time permitted, the trial
court shall determine if the plaintiff has established prima-facie evidence of
physical impairment in a timely manner based on the papers and documentation
submitted to the trial court;
(D)
If a defendant files an objection, then within ten days of service of
defendant́s
opposition, the plaintiff may file a reply with the trial court. The reply must
be served on each defendant; and
(E)
The trial court shall determine if the plaintiff has established prima-facie
evidence of physical impairment in a timely manner based on the papers and
documentation submitted to the trial court. A hearing will be conducted only if
the trial court so orders on its own motion, or if, in the exercise of
discretion, the trial court grants a
partýs
request for a hearing. No testimony shall be taken at the hearing. A decision of
the trial court not to grant a request for a hearing may not be appealed and
does not constitute reversible error. If the trial court determines that the
plaintiff has failed to establish prima-facie evidence of physical impairment,
it shall dismiss the
plaintiff́s
complaint without prejudice; or
(3)
In the event a trial is scheduled to commence in less than 60 days from the
effective date of this chapter, a trial court can shorten the deadlines
contained in this subsection as necessary in order to make a determination
regarding the prima-facie evidence of physical impairment before trial
commences.
(b)(1)
The plaintiff in any asbestos claim or silica claim filed in this state on or
after the effective date of this chapter shall file together with the complaint
a medical affidavit and accompanying documentation setting forth the medical
findings necessary to establish prima-facie evidence of physical impairment as
provided in paragraph (15) or (16) of Code Section 15-14-2. In addition, the
plaintiff́s
complaint shall allege with specificity that the plaintiff satisfies the
prima-facie evidence of physical impairment with respect to an asbestos claim or
silica claim.
(2)
Within 90 days of service of
plaintiff́s
complaint, any defendant may file an opposition with the trial court challenging
plaintiff́s
prima-facie evidence of physical impairment. To the extent any such opposition
is based upon the medical opinion of a licensed physician, that physician shall
be a qualified physician, as that term is defined in subparagraph (A) of
paragraph (17) of Code Section 51-14-2, and shall be either a board certified
internist, a board certified pathologist, a board certified pulmonologist, or a
certified B-reader.
Defendant́s
opposition shall be filed with the trial court and served on
plaintiff́s
counsel and each defendant.
(3)
If the defendant does not file an opposition challenging
plaintiff́s
prima-facie evidence of physical impairment within the time permitted, the trial
court shall determine if the plaintiff has established prima-facie evidence of
physical impairment based on the papers and documentation submitted to the trial
court. The trial
court́s
decision shall be made in a timely manner.
(4)
If the defendant files an objection, the plaintiff may file a reply with the
trial court within ten days of service of
defendant́s
opposition. The reply must be served on each defendant.
(5)
The trial court shall determine if the plaintiff has established prima-facie
evidence of physical impairment with respect to an asbestos claim or silica
claim in a timely manner based on the papers and documentation submitted to the
trial court. A hearing will be conducted only if the trial court so orders on
its own motion, or if, in the exercise of discretion, the trial court grants a
partýs
request for a hearing. No testimony shall be taken at the hearing. A decision of
the trial court not to grant a request for a hearing may not be appealed and
does not constitute reversible error. If the trial court determines that the
plaintiff has failed to establish prima-facie evidence of physical impairment,
it shall dismiss the
plaintiff́s
complaint without prejudice.
51-14-6.
(a)
All asbestos claims and silica claims filed in this state on or after the
effective date of this chapter shall include a sworn information form containing
the following information:
(1)
The exposed
persońs
name, address, date of birth, social security number, and marital
status;
(2)
If the exposed person alleges exposure to asbestos or silica through the
testimony of another person or other than by direct or bystander exposure to a
product or products, the name, address, date of birth, social security number,
and marital status for each person by which claimant alleges exposure, hereafter
the 'index person,' and the
claimant́s
relationship to each person;
(3)
The specific location of each alleged exposure;
(4)
The specific asbestos-containing product or silica-containing product to which
the exposed person was exposed and the manufacturer of each
product;
(5)
The beginning and ending dates of each alleged exposure as to each
asbestos-containing product or silica-containing product for each location at
which exposure allegedly took place for plaintiff and for each index
person;
(6)
The occupation and name of employer of the exposed person at the time of each
alleged exposure;
(7)
The specific condition related to asbestos or silica claimed to exist;
and
(8)
Any supporting documentation of the condition claimed to exist.
(b)
All asbestos claims and silica claims along with sworn information forms must be
individually filed in separate civil actions except that claims relating to the
exposure to asbestos or silica for the same exposed person whose alleged injury
is the basis for the civil action may be joined in a single action. Otherwise,
no claims on behalf of a group or class of persons shall be joined in single
civil action.
51-14-7.
(a)
Until such time as the trial court enters an order determining that the
plaintiff has established prima-facie evidence of physical impairment, no
asbestos claim or silica claim shall be subject to discovery, except discovery
related to establishing or challenging the prima-facie evidence of physical
impairment or by order of the trial court upon motion of one of the parties and
for good cause shown.
(b)
The medical criteria set forth in this chapter to establish prima-facie evidence
of physical impairment are solely for the purpose of determining whether a claim
meets the criteria to proceed in court. The fact that a plaintiff satisfies the
criteria necessary to establish prima-facie evidence of physical impairment for
an asbestos claim or silica claim shall not be construed as an admission or
determination that the exposed person in fact has a condition related to
exposure to asbestos or silica and shall not be cited, referred to, or otherwise
used at trial.
(c)
Unless stipulated to by the parties, an expert report submitted for the purpose
of establishing or challenging prima-facie evidence of physical impairment is
inadmissible for any other purpose.
51-14-8.
(a)
Notwithstanding Code Section 1-2-6 or 1-2-10, a civil action alleging an
asbestos claim or silica claim may only be brought or maintained in the courts
of Georgia if the plaintiff, whether a citizen of Georgia or a citizen of some
other state, is a resident of Georgia at the time of filing the action or the
exposure to asbestos or silica on which the claim is based occurred in Georgia;
provided, however, nothing contained in this chapter shall preclude a
nonresident of Georgia who currently has a case pending in this state on the
effective date of this chapter from maintaining an asbestos claim or silica
claim if that nonresident can establish prima-facie evidence of physical
impairment with respect to an asbestos claim or silica claim as provided in
paragraph (15) or (16) of Code Section 51-14-2.
(b)
The trial court, on motion of a defendant, shall dismiss each asbestos claim or
silica claim that is subject to this chapter against the defendant unless the
plaintiff files a written statement with the trial court electing to abate the
plaintiff́s
claim against the defendant for a period of 180 days from the date the trial
court disposes of the
defendant́s
motions in order to afford the plaintiff an opportunity to file a new action on
the claims in another state of the United States.
(c)(1)
A trial court may not abate or dismiss a claim under this Code section until the
defendant files with the trial court or with the clerk of the court a written
stipulation that, with respect to a new action on the claim commenced by the
plaintiff, the defendant waives the right to assert a statute of limitations
defense in all other states of the United States in which the claim was not
barred by limitations at the time the claim was filed in this state as necessary
to effect a tolling of the limitations periods in those states beginning on the
date the claim was filed in this state and ending on the date the claim is
dismissed or the period of abatement ends. The fact that a claim subject to this
Code section was barred by the statute of limitations in all other states of the
United States at the time it was filed in this state shall not prevent the claim
from being dismissed pursuant to this Code section and such claim shall be
dismissed even if it can not be filed in another state. The trial court may not
abate or dismiss a claim under this Code section until the defendant files with
the trial court or with the clerk of the court a written stipulation that, with
respect to a new action on the claim commenced by the plaintiff in another state
of the United States, the plaintiff may elect that the plaintiff and the
defendant may rely on responses to discovery already provided under the Georgia
Civil Practice Act, plus any additional discovery that may be conducted under
the rules of civil procedure in another state, or use responses to discovery
already provided and conduct additional discovery as permitted under the rules
of civil procedure in such other state.
(2)
If less than all of the defendants agree to provide the stipulations set forth
in paragraph (1) of this subsection, then the court shall dismiss the claims of
those defendants who so stipulate.
(d)
To comply with this Code section in relation to an action that involves both
claims that arose in this state and claims that arose outside this state, a
trial court shall consider each claim individually and shall sever from the
action the claims that are subject to this Code section.
(e)
If a plaintiff alleges that the exposed person was exposed to asbestos or silica
while located in more than one jurisdiction, the trial court shall determine,
for purposes of this Code section, which of the jurisdictions is the most
appropriate forum for the claim, considering the relative amounts and lengths of
the exposed
persońs
exposure to asbestos or silica in each jurisdiction.
51-14-9.
Notwithstanding
any other provision of law, an asbestos claim or silica claim that meets the
requirements of this chapter permitting a claim to be filed in this state may
only be filed in the county where the plaintiff resides or the county in which
the exposure to asbestos or silica on which the claim is based occurred and that
exposure was a substantial contributing factor to the physical impairment of the
exposed person on which the
plaintiff́s
claim is based. If a plaintiff alleges that an exposed person was exposed to
asbestos or silica while located in more than one county, the trial court shall
determine which of the counties is the most appropriate forum for the claim,
considering the relative amounts and lengths of the exposed
persońs
exposure to asbestos or silica in each of those counties.
51-14-10.
A
trial court may consolidate for trial any number and type of asbestos claims or
silica claims with the consent of all the parties. In the absence of such
consent, the trial court may consolidate for trial only asbestos claims or
silica claims relating to the same exposed person and members of his or her
household."
SECTION
2.
In
the event any section, subsection, sentence, clause, or phrase of this Act shall
be declared or adjudged invalid or unconstitutional, such adjudication shall in
no manner affect the other sections, subsections, sentences, clauses, or phrases
of this Act, which shall remain of full force and effect as if the section,
subsection, sentence, clause, or phrase so declared or adjudged invalid or
unconstitutional were not originally a part hereof. The General Assembly
declares that it would have passed the remaining parts of this Act if it had
known that such part or parts hereof would be declared or adjudged invalid or
unconstitutional.
SECTION
3.
This
Act shall become effective upon its approval by the Governor or upon its
becoming law without such approval and applies to all asbestos claims or silica
claims filed on or after the effective date and to any pending asbestos claims
or silica claims in which trial has not commenced as of the effective
date.
SECTION
4.
All
laws and parts of laws in conflict with this Act are repealed.
